Edition:
United Kingdom

Allied Minds PLC (ALML.L)

ALML.L on London Stock Exchange

72.30GBp
11:18am BST
Change (% chg)

1.10 (+1.54%)
Prev Close
71.20
Open
72.50
Day's High
72.50
Day's Low
71.90
Volume
30,675
Avg. Vol
233,076
52-wk High
190.00
52-wk Low
70.12

Summary

Name Age Since Current Position

Peter Dolan

2016 Non-Executive Chairman of the Board

Jill Smith

60 2017 President, Chief Executive Officer, Executive Director

Michael Turner

49 2015 Company Secretary

Fritz Foley

2018 Independent Non-Executive Director

Harry Rein

71 2017 Non-Executive Independent Director

Jeffrey Rohr

66 Independent Non-Executive Director

Kevin Sharer

67 2015 Independent Non-Executive Director

Svetoslav Milenkov

37 2015 Director - Finance

Biographies

Name Description

Peter Dolan

Mr. Peter Robert Dolan is an Non-Executive Chairman of the Board of the Company. He joined Allied Minds in April 2014. Peter has 30 years of operating experience, including 18 years at Bristol-Myers Squibb, where he served as Chairman and Chief Executive Officer. He subsequently served as Chairman and Chief Executive Officer of Gemin X, a venture capital backed oncology company that was sold to Cephalon. Peter is the Chairman of the Board of Trustees of Tufts University having served in several leadership capacities, including Vice Chair, and as a member of the Compensation, Academic Affairs and Audit Committees, before his election as Chairman in November 2013. Most recently, Peter served on the Board of Overseers of the Tuck School at Dartmouth College and on the Board of Directors of the National Centre on Addiction and Substance Abuse at Columbia University. Additionally, he has served on the Boards of the American Express Company, C-Change (a cancer coalition organisation), and was Chairman of the Pharmaceutical Research and Manufacturers of America. Peter holds a Bachelor of Arts degree from Tufts University in Social Psychology and a Master of Business Administration degree from the Amos Tuck School of Business at Dartmouth. Peter was appointed to the Board in May 2014, and has served as Chairman since May 2015.

Jill Smith

Ms. Jill D. Smith is President, Chief Executive Officer, Executive Director of the Company. She has more than 25 years of experience as an international business leader, including 16 years as Chief Executive Officer of private and public companies in the technology and information services markets. Most recently, Jill served as Chairman, Chief Executive Officer and President of DigitalGlobe Inc. (NYSE:DGI), a global provider of satellite imagery products and services. Beginning her career as a consultant at Bain & Company, where she rose to become Partner, other leadership capacities in which she has served include Vice President of Sara Lee, Chief Executive Officer and President of eDial, Chief Executive Officer and President of SRDS, L.P., Chief Operating Officer of Micron Electronics, and Co-Founder of Treacy & Company, a consulting and boutique investment business. Currently, Jill serves as an independent director on the Boards of Directors of Endo International plc (NASDAQ: ENDP), Gemalto N.V. (Euronext: GTO), and J.M. Huber Corporation. She will not be standing for re-election at the Endo AGM in June 2018. Jill also expects to resign from the Board of Gemalto in the second half of 2018, when Gemalto expects to complete its sale to Thales (Euronext Paris: HO). Jill holds a Master of Science degree in Business Administration from the MIT Sloan School of Management. Jill served as a member of the Audit Committee until March 2017, when she was replaced by Kevin Sharer upon her appointment as Chief Executive Officer, President and Executive Director.

Michael Turner

Mr. Michael Scott Turner is Company Secretary of the Company. Before joining Allied Minds, Michael was a Partner of DLA Piper LLP (US), one of the largest international business law firms, where he was a member of the Corporate and Finance Group. Prior to joining DLA, Michael was a Partner in the Corporate Group of Goodwin Procter LLP, a Boston-based national law firm. Michael acted as outside general counsel to public and private companies, investment banks, and private equity and venture capital firms, with an emphasis on serving the needs of growth companies in the software, semiconductor, data storage, analytics, telecommunications, medical devices and biotechnology sectors. During his more than 15 years in private practice, Michael provided counsel on company formation, equity and debt financings, public offerings, mergers and acquisitions, strategic partnerships, intellectual-property transactions, executive compensation, employment law, and other operational and transactional matters. Michael is admitted to the bar in Massachusetts and New York, and earned a BA in Political Science and Economics from Colgate University, and his JD in Business Law and Regulation from Cornell Law School.

Fritz Foley

Mr. Fritz Foley is Independent Non-Executive Director of the Company. Fritz Foley is the André R. Jakurski Professor and Senior Associate Dean for Strategic Financial Planning at Harvard Business School (HBS) where his research focuses on corporate finance. Prior to joining the HBS faculty in 2004, he taught at the University of Michigan Business School. He has published papers on investment, capital structure, working capital management, dividend policy, joint ventures, intellectual property, and corporate tax policy, and has advised firms in technology, biotech, retail, health care, professional services, and other industries on financial matters and strategic choices. He has also served as a trustee for several nonprofit organizations. Mr. Foley gained his Ph. D. in Business Economics from Harvard University and his B.A. in Ethics, Politics, and Economics from Yale University.

Harry Rein

Mr. Harry T. Rein serves as Non-Executive Independent Director of the Company. Harry brings extensive experience from the venture capital sector, most recently serving as General Partner for 10 years at Foundation Medical Partners, having been instrumental in its formation. Foundation is an early stage venture capital firm focused on the healthcare sector. Prior to Foundation, Harry served as Founder and Managing Partner at Canaan Partners. Harry was responsible for life sciences investments at both Foundation and Canaan. Prior to Canaan, Harry was President and CEO of GE Venture Capital Corporation, having joined General Electric Company in 1979. He directed several of General Electric’s lighting businesses before joining the venture capital subsidiary. Mr Rein currently serves on the Board of DeliverCareRX and served on the Board of Anadigics (NASDAQ: ANAD) until 2016. He has served on the Board of over 20 public and private entrepreneurial companies, including: Cell Pathways; OraPharma; National MD; OmniSonics; GenVec (NASDAQ: GNVC); CardioNet (NASDAQ: BEAT) and Spine Wave, and was an investor in Praecis Pharmaceuticals (NASDAQ: PRCS). Mr Rein attended Emory University and Oglethorpe College (1969) and holds a MBA from the Darden School at the University of Virginia (1973). Harry serves on each of the Audit and Remuneration Committees.

Jeffrey Rohr

Mr. Jeffrey P. Rohr is an Independent Non-Executive Director of the Company. He joined Allied Minds in April 2014. He has 30 years of senior management experience at Deloitte LLP. Jeff has career long experience serving clients in a multitude of industries and extensive experience in governance processes having last served in the role of Vice Chairman and Chief Financial Officer at Deloitte. In the role of Chief Financial Officer, Jeff was responsible for all aspects of financial affairs of the Deloitte Global Firm and the Deloitte US Firm, including strategy, accounting and financial reporting, treasury, capital adequacy, liquidity, taxes, pensions, and risk management. Previously, Jeff served as the Managing Partner of Deloitte’s Midwest and Mid-Atlantic regions as well as National Director of Deloitte’s Business Planning. Currently, Jeff serves on a number of Boards and Foundations. He is a member of the Board of Directors of American Express Centurion Bank where he is the Chairman of the Audit and Risk Committee, has served for ten years as Chairman of the Audit Committee of the Florida State University Foundation Board of Trustees and is Chairman of the College of Business Board of Governors. Jeff is a graduate of Florida State University with a B.S. degree in Accounting and is a Certified Public Accountant. Jeff was appointed to the Board in May 2014, and serves on each of the Audit (Chairman), Nomination, and Remuneration Committees.

Kevin Sharer

Mr. Kevin W. Sharer is Independent Non-Executive Director of the Company. He joined Allied Minds in June 2015. Globally recognised as a leader and mentor to senior management teams engaged in high-growth strategies, Kevin spent more than 20 years leading Amgen, the world’s largest independent biotechnology firm, starting as President and Chief Operating Officer and then taking over as Chairman and Chief Executive Officer. Kevin began his career in the United States Navy, serving as Chief Engineer on the USS Memphis and later rising to become a Lieutenant Commander. After his service, Kevin worked as a consultant at McKinsey & Co., in corporate development at General Electric Co., and as an Executive Vice President in Marketing at MCI Telecommunications Corp. Having previously served on the Boards of Directors of Chevron Corp. and Northrop Grumman Corp., Kevin is currently a faculty member at Harvard Business School, where he teaches General Management and other classes. Kevin holds a Bachelor of Science degree and a Master of Arts degree in Engineering from the United States Naval Academy and a Master of Business Administration degree from the University of Pittsburgh’s Joseph M. Katz Graduate School of Business. Kevin was appointed to the Board in June 2015, and serves on each of Nomination, and Remuneration (Chair) Committees, and served on the Audit Committee from March 2017 until November 2017 when he was replaced by Harry Rein.

Svetoslav Milenkov

Mr. Svetoslav Milenkov is Director - Finance of the Company. Before joining Allied Minds, Sam (Svetoslav) was a manager for KPMG’s Audit and Risk Advisory practice with close to seven years of audit experience across the full cycle of an audit engagement. His credentials span across a broad variety of industries, including a background in consumer products, retail, technology and early stage R&D companies ranging from start-ups to large multi-national private and public corporations. In 2011, Sam completed an 18 months rotation at the KPMG Vienna, Austria office where he was able to integrate his experience in US GAAP and IFRS. Sam is a Certified Public Accountant with the State of Massachusetts and received his M.S in Accounting and BSBA in Accounting and International Business from Suffolk University, Boston.

Basic Compensation

Name Fiscal Year Total

Peter Dolan

164,000

Jill Smith

635,000

Michael Turner

--

Fritz Foley

--

Harry Rein

21,000

Jeffrey Rohr

109,000

Kevin Sharer

94,000

Svetoslav Milenkov

--
As Of  31 Dec 2017